FOXD1 Regulates the Sensitivity of Cetuximab by Regulating the Expression of EGFR in Head and Neck Squamous Cell Cancer
- Type
- Retraction
- Notice date
- 7/26/2023 0:00
- Journal
- Journal of Healthcare Engineering
- Publisher
- Hindawi
- Notice DOI
- 10.1155/2023/9818213
- Original paper DOI
- 10.1155/2022/6108241
Reasons
- Concerns/Issues about Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues about Peer Review
- Investigation by Journal/Publisher
- Unreliable Results and/or Conclusions